| Transitional Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived115 of 115show fewer |
|---|
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 95 trials (50 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 95 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 68 trials (36 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 68 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 50 trials (27 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal_antibody 36 trials (18 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 35 trials (27 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 34 trials (15 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal_antibody 32 trials (7 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 32 trials (14 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal_antibody 24 trials (8 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 22 trials (10 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal_antibody 19 trials (13 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 15 trials (3 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 14 trials (9 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 14 trials (8 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 14 trials (12 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 11 trials (6 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 11 trials (5 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall_molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinfluninesmall_molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall_molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Infigratinibsmall_molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rogaratinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bacillus Calmette-Guerin BCG 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dactolisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lucitanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mocetinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nadofaragene Firadenovecgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nogapendekin Alfa Inbakiceptother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PD1 Inhibitor 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tovorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valrubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |